DURAND REMY

CIK 00019730271 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001973027

Recent Transactions

20 trades

Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−2,635→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−112,500→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−26,922→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−78,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−102,192→ 31,200 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−70,155→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−109,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-20−31,200→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-08−12,365→ 2,635 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-08−10,000→ 0 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-08−38,078→ 26,922 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-08$6.51/sh+25,000→ 72,949 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-08$4.09/sh+12,365→ 85,314 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-08$3.23/sh+38,078→ 123,392 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-08$13.20/sh+9,845→ 47,949 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-08$4.76/sh+10,000→ 133,392 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-08−9,845→ 70,155 total
Exercise/Conversion
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-08−25,000→ 0 total
Award
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-04+31,200→ 38,104 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-04+78,000→ 78,000 total

Companies

ALPINE IMMUNE SCIENCES, INC.
Chief Business Officer

Recent Filings

Address

C/O ALPINE IMMUNE SCIENCES, INC. 188 EAST BLAINE STREET, SUITE 200

SEATTLE, WA, 98102

View on SEC.gov